RecruitingPhase 1NCT03759522

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.


Sponsor

University of Alabama at Birmingham

Enrollment

120 participants

Start Date

Feb 3, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this study is to measure the concentration and the regional brain distribution of activated brain microglia/macrophages using the PET radiopharmaceutical \[F-18\]DPA-714 in individuals with chronic pain and fatigue suspected to be associated with neuroinflammation. The PET tracer \[F-18\]DPA-714 binds to the 18 kDa translocator protein (TSPO, also known as the peripheral benzodiazepine receptor) in the mitochondria of activated microglia/macrophages and provides a non-invasive measure of neuroinflammation. The primary objective of this study is to determine if pain and fatigue patients have higher levels of neuroinflammation than HC individuals as measured with \[F-18\]DPA-714-PET/MRI.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial is using a specialized brain scan called a PET scan (with a tracer called DPA-714) to look for inflammation in the brain and nervous system in people with multiple sclerosis (MS), fibromyalgia, or chronic fatigue syndrome, to better understand these conditions. **You may be eligible if...** - You are aged 18–65 years - You are a healthy volunteer, OR have a confirmed diagnosis of multiple sclerosis (MS), fibromyalgia, or chronic fatigue syndrome (CFS/ME) - You are able to undergo MRI and PET brain scans **You may NOT be eligible if...** - You have a contraindication to MRI (e.g., certain metal implants) - You are pregnant or breastfeeding - You have a chronic infectious disease (such as HIV or Hepatitis C) - You had a recent viral or bacterial illness requiring antibiotics - Your medical condition is too severe to participate in the imaging procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDPA-714 PET/MRI

DPA-714 PET/MRI


Locations(1)

University of Alabama at Birmingham Medical Center

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03759522


Related Trials